These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17372150

  • 1. Normalization of the IGF-IGFBP axis by sustained nightly insulinization in type 1 diabetes.
    Ekström K, Salemyr J, Zachrisson I, Carlsson-Skwirut C, Ortqvist E, Bang P.
    Diabetes Care; 2007 Jun; 30(6):1357-63. PubMed ID: 17372150
    [Abstract] [Full Text] [Related]

  • 2. Treatment with insulin glargine does not suppress serum IGF-1.
    Slawik M, Schories M, Busse Grawitz A, Reincke M, Petersen KG.
    Diabet Med; 2006 Jul; 23(7):814-7. PubMed ID: 16842489
    [Abstract] [Full Text] [Related]

  • 3. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J, Urban M, Głowińska B, Urban B.
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [Abstract] [Full Text] [Related]

  • 4. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
    Bereket A, Lang CH, Wilson TA.
    Horm Metab Res; 1999 Apr; 31(2-3):172-81. PubMed ID: 10226799
    [Abstract] [Full Text] [Related]

  • 5. Nocturnal blood glucose and IGFBP-1 changes in type 1 diabetes: Differences in the dawn phenomenon between insulin regimens.
    Yagasaki H, Kobayashi K, Saitou T, Nagamine K, Mitsui Y, Mochizuki M, Kobayashi K, Cho H, Ohyama K, Amemiya S, Nakazawa S.
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):195-9. PubMed ID: 19834874
    [Abstract] [Full Text] [Related]

  • 6. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B, Blum WF, Mehls O.
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [Abstract] [Full Text] [Related]

  • 7. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM, Yuen K, White D, Mallard B, Dalton RN, Acerini CL, Dunger DB.
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [Abstract] [Full Text] [Related]

  • 8. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 9. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
    Hedman CA, Frystyk J, Fridell K, Jönsson A, Flyvbjerg A, Lindström T, Arnqvist HJ.
    Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
    [Abstract] [Full Text] [Related]

  • 10. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
    Zachrisson I, Brismar K, Carlsson-Skwirut C, Dahlquist G, Wallensteen M, Bang P.
    Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
    [Abstract] [Full Text] [Related]

  • 11. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.
    Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Rosenfeld R, Tauber JP.
    Diabetes Metab; 1996 Jul; 22(4):245-50. PubMed ID: 8767170
    [Abstract] [Full Text] [Related]

  • 12. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.
    Growth Horm IGF Res; 2006 Jul; 16(5-6):332-9. PubMed ID: 17067837
    [Abstract] [Full Text] [Related]

  • 13. Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.
    Christ ER, Carroll PV, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Sönksen PH, Russell-Jones DL.
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1154-62. PubMed ID: 11934682
    [Abstract] [Full Text] [Related]

  • 14. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P, Zwimpfer C, Zapf J, Schmid C.
    Acta Obstet Gynecol Scand; 2006 May; 85(8):900-5. PubMed ID: 16862465
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F, Yaylali GF, Turgut S, Kaptanoglu B.
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [Abstract] [Full Text] [Related]

  • 16. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J, Urban M, Urban B, Głowińska B, Florys B.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004 Jun; 10(1):41-8. PubMed ID: 15355738
    [Abstract] [Full Text] [Related]

  • 17. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
    Mericq V, Román R, Iñiguez G, Angel B, Salazar T, Avila A, Perez-Bravo F, Cassorla F.
    Horm Res; 2007 Jun; 68(3):132-8. PubMed ID: 17347571
    [Abstract] [Full Text] [Related]

  • 18. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA.
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [Abstract] [Full Text] [Related]

  • 19. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH, Wildschiødtz G, Juul A, Hilsted J.
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [Abstract] [Full Text] [Related]

  • 20. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO, Dunger DB.
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.